We performed a 10-year retrospective analysis of the frequency of local postoperative infectious complications in methotrexate (MTX)-treated rheumatoid arthritis patients who underwent total joint arthroplasty. Sixty patients, who had a total of 92 joint arthroplasties, were receiving MTX. A comparison group of 61 patients with a combined total of 110 total joint arthroplasties were not receiving MTX. The 2 groups were compared for the occurrence of local postoperative infectious complications and poor wound healing. Eight patients in the MTX group experienced a total of 8 complications (8.7% of procedures). In comparison, 5 patients in the non-MTX group experienced a total of 6 complications (5.5% of procedures), a difference that was not statistically significant (chi 2 = 0.816, P = 0.366). Statistical analysis of many other variables revealed none that could be identified as risk factors for postoperative complications. These results suggest that treatment in the perioperative period with weekly low-dose pulse MTX does not increase the risk of local postoperative infectious complications or poor wound healing in rheumatoid arthritis patients who undergo total joint arthroplasty.





Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
100% Article relates to my practice (5/5)
0% Article does not relate to my practice (0/5)
0% Undecided (0/5)
2

Will this article lead to more cost-effective healthcare?

40% Yes (2/5)
40% No (2/5)
20% Undecided (1/5)
3

Was this article biased? (commercial or personal)

0% Yes (0/5)
100% No (5/5)
0% Undecided (0/5)
4

What level of evidence do you think this article is?

0% Level 1 (0/5)
20% Level 2 (1/5)
80% Level 3 (4/5)
0% Level 4 (0/5)
0% Level 5 (0/5)